Assistant Professor of Medicine

Division of Cardiology
San Francisco General Hospital
1001 Potrero Ave., 5G1
UCSF Box 0846
San Francisco, CA 94110

Phone: (415) 206-6615
Fax: (415) 206-5447
email: rfarzanehfar@medicine.ucsf.edu

• Medical School: University of London, MD, 2002, Royal Free & University College Medical School
• Residency: Brigham & Womens Hospital, Harvard Medical School Residency, Internal Medicine, 2003-2006
• Fellowship: University of California-San Francisco, Fellowship, Cardiovascular Medicine, 2006-2009
• University of California, San Francisco, Masters in Clinical Research, 2008-2010
• Certifications:
• Amercian Board of Internal Medicine, 2006
• Board Eligibility, Cardiovascular Medicine, 2009

Research Interests

Dr. Farzaneh-Far is a cardiovascular epidemiologist and clinical cardiologist with research interests in the identification, development, and assessment of novel biomarkers. He is currently studying the significance and dynamics of telomeric aging in cardiovascular disease. Dr. Farzaneh-Far joined the division in 2009, and is a recipient of the American Heart Association's Fellow-to-Faculty Transition Award.

Clinical Interests

• Preventive cardiology
• Echocardiography
• Hemodynamics
• Diastolic heart failure

Selected Recent Publications

• Farzaneh-Far R, Schwarzberg T, and Mushlin S. Thinking outside the box. N Engl J Med 2006;354(22):2376-81
• Farzaneh-Far R, Dang D, Roberts J, Schiller NB, Foster E. Accuracy of Doppler-estimated pulmonary vascular resistance in pre-liver transplant patients.Am J Cardiol. 2008;101(2):259-62.
• Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Usefulness of noninvasive estimate of pulmonary vascular resistance to predict mortality, heart failure, and adverse cardiovascular events in patients with stable coronary artery disease (from the Heart and Soul Study). Am J Cardiol. 2008;101(6):762-6
• Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 2008;28(7):1379-1384
• Farzaneh-Far R, Farzaneh-Far A. Cardiovascular events during World Cup soccer. N Engl J Med. 2008;358(22):2408-9
• Stevens SM, Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: The Heart and Soul Study. J Am Coll Cardiol Img 2009;2(1):11-20
• Farzaneh-Far R, Harris WS, Na B, Garg S, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009;205(2):538-543
• Farzaneh-Far R, Na B, Schiller NB, Whooley MA. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure, function, and events in persons with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009;205(2):492-496
• Spies C, Farzaneh-Far R, Na B, Kanaya A, Schiller NB, Whooley MA. Obesity, heart failure and cardiovascular events in persons with stable coronary artery disease: the Heart and Soul Study. Am J Cardiol (in press)
• Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Left ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study. Cardiology 2009;114(3):226-234